Effectiveness of Cannabinoids on Appetite in Scleroderma

Summary

The cannabinoid has benefits in many aspects but the evidence of the effect of cannabinoids in humans with SSc is limited. We, therefore, would like to investigate the efficacy of cannabinoids on the appetite, sleep efficiency, quality of life, pain, and critical cytokine level in SSc compared with placebo in SSc patients and the adverse events associated with cannabinoids in those patients.

Timeline

Start

2022-11-09

Primary completion

2024-10-31

Completion

2024-12-31

Publications

• Pisprasert V, Sripanichkulchai B, Khannongpho T, Jumnainsong A, Mahakkanukrauh A, Suwannaroj S, Pongkulkiat P, Onchan T, Kanokmedhakul S, So-Ngern A, Foocharoen C. Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial. J Cannabis Res. 2025 Oct 24;7(1):82. doi: 10.1186/s42238-025-00342-3.

Drugs

Indications